Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes.
Eye (Lond)
; 38(3): 628-630, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37749373
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleritis
Limits:
Humans
Language:
En
Journal:
Eye (Lond)
Journal subject:
OFTALMOLOGIA
Year:
2024
Document type:
Article
Affiliation country: